Tips for Wegovy: Making the Evidence Work for You

Semaglutide works partly by slowing gastric emptying, which means eating slowly and stopping when full is no longer just good advice — it actively supports what the medicine is already doing.
The dose escalation schedule (starting at 0.25mg and titrating upward roughly every four weeks) exists to reduce gastrointestinal side effects, not to be rushed; your prescriber sets the pace.
Protein adequacy, hydration and some resistance activity help preserve muscle during significant weight loss — a point the STEP trial programme built into its lifestyle component.
Wegovy is a Black Triangle (▼) medicine, meaning it carries additional MHRA monitoring; reporting any unexpected side effect via the Yellow Card scheme contributes to that safety picture for everyone.

Clinical trial data gives us a clear picture: in the STEP 1 trial, adults using semaglutide 2.4mg alongside lifestyle changes lost an average of around 15% of their body weight over 68 weeks. That figure came from a structured programme, and the structure mattered. Wegovy is a prescription-only medicine requiring clinical assessment before it can be dispensed, and the practical habits you build around it shape how closely your own results track those trial outcomes. These tips are drawn from NHS England's guidance on weight-management injections and the published clinical evidence, not from anecdote.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Evidence-based habits that complement how semaglutide actually works

What the STEP 1 data tells us about the role of lifestyle

The 15% average weight reduction in the STEP 1 trial, published in the New England Journal of Medicine, was not achieved by the injection alone. Participants followed a reduced-calorie diet and increased their physical activity alongside treatment. The medicine suppresses appetite through GLP-1 receptor activation and slows the rate at which the stomach empties, but it cannot redesign eating habits on its own. Practically, that means the trial's results are most replicable when you treat the lifestyle component as part of the prescription, not a footnote to it.

One thing many people find useful early in treatment is keeping meals smaller than usual and chewing slowly. Because semaglutide delays gastric emptying, eating quickly and then waiting to feel full can tip into discomfort. The nausea that's common in the first weeks tends to be worst after large or fatty meals. Spreading food across the day rather than front-loading at a few sittings gives the medicine's mechanism room to work without fighting your gut at the same time.

Protein deserves particular attention. Significant weight loss, however it's achieved, tends to include some muscle loss unless protein intake is kept up and some resistance activity maintained. There's no specific target on your prescription, but NHS guidance on weight-management treatment consistently flags this point, and it's worth raising with your prescriber or a dietitian early rather than retrospectively. You can read more about the full Wegovy treatment overview on our information page.

Injection technique and timing: the details that actually change your experience

Semaglutide is injected subcutaneously (under the skin) once weekly, in the abdomen, thigh or upper arm. Rotating the injection site each week reduces the chance of localised skin reactions such as redness or thickening, which become more likely if the same spot is used repeatedly. The pen should be stored in the fridge at 2–8°C until it's first used; after that, check the Patient Information Leaflet for the exact out-of-fridge window because that detail varies by product and must not be guessed at.

Consistency of timing matters more than most people expect. Injecting on the same day each week keeps drug levels steadier, which may help keep appetite suppression more predictable across the week. The day itself is flexible, pick one that fits your routine and stick with it. If you're wondering how Wegovy sits alongside similar treatments, a factual comparison of Wegovy with other weight-loss options is on our site.

One question the prescribers at nume hear regularly is whether the day of injection affects side effects. There's no clinical trial answer to that, but choosing a day where you have a lighter schedule in the following 24 hours is a practical hedge worth considering, especially during the early dose-escalation phase when nausea is most common.

Managing side effects without undermining the treatment

Nausea, loose stools, constipation and indigestion are the most frequently reported side effects, and the pattern in the STEP programme was consistent: they peak around dose increases and tend to ease within one to two weeks as the body adjusts. The clinical advice, reflected in the NHS semaglutide information page, is to avoid high-fat or spicy meals during this window, stay well hydrated (particularly if vomiting or diarrhoea occur) and eat smaller portions.

Dehydration from persistent GI symptoms is the risk that warrants prompt medical attention, not just tolerance. If you cannot keep fluids down for more than a day, contact your prescriber or GP. Severe, persistent stomach pain that radiates toward the back is a signal to seek urgent help, it is associated with pancreatitis, which is a known but infrequent side effect of GLP-1 medicines. The MHRA has highlighted this in published safety communications, and it should not be waited out at home.

Constipation catches people off guard because nausea gets more coverage. Increasing fibre and fluid intake from the start, rather than reactively, tends to help. If you have further questions about managing these effects or your dose progression, our frequently asked questions page covers the most common concerns, and our aftercare team is available seven days a week. Separately, if you're thinking about cost as part of your planning, the Wegovy price comparison page explains what legitimate private treatment typically involves.

Longer-term habits: sustaining progress past the initial months

Trial evidence consistently shows that weight tends to return when GLP-1 treatment stops without accompanying behaviour change. The medicine shifts appetite and makes good habits easier to build; the habits are what hold the progress when the medicine ends or is paused. This is the basis for NHS England's insistence on wrap-around lifestyle support alongside any medically supervised weight-loss treatment.

Practically, the months of treatment are an opportunity to recalibrate portion awareness, food preferences and activity levels while appetite suppression is working in your favour. Several of the people who get the most from semaglutide treatment describe building a sustainable eating pattern during the period when appetite is at its most reliably reduced, and if you want practical guidance on making the most of that window, our page on tips for getting the best results from Wegovy is worth reading alongside your clinical advice. If you'd like to understand the eligibility criteria before starting, the age and eligibility criteria for Wegovy are covered separately.

Reassessment at six months is clinically meaningful. NICE guidance on semaglutide specifies that treatment should be reviewed if weight loss is less than 5% at the maintenance dose after six months. That review is a clinical conversation about whether to continue, adjust or reconsider, not an automatic stop. At nume, every repeat order goes through a fresh clinical review; there are no auto-renewals. If you want to explore whether treatment is right for you, the starting point is a free consultation with our prescribers, and if you have come across different brand names and alternative names used for Wegovy, our dedicated page explains what they refer to and how they relate to the same treatment.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions